nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCC2—bile canaliculus—sclerosing cholangitis	0.179	0.421	CbGeAlD
Arsenic trioxide—ABCC2—bile duct—sclerosing cholangitis	0.056	0.132	CbGeAlD
Arsenic trioxide—ABCC2—bile—sclerosing cholangitis	0.043	0.101	CbGeAlD
Arsenic trioxide—CCND1—pancreas—sclerosing cholangitis	0.0165	0.0388	CbGeAlD
Arsenic trioxide—TXNRD1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0143	0.0248	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.014	0.0243	CbGpPWpGaD
Arsenic trioxide—MAPK1—pancreas—sclerosing cholangitis	0.0139	0.0327	CbGeAlD
Arsenic trioxide—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.013	0.0226	CbGpPWpGaD
Arsenic trioxide—TXNRD1—pancreas—sclerosing cholangitis	0.013	0.0304	CbGeAlD
Arsenic trioxide—CCND1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.0126	0.022	CbGpPWpGaD
Arsenic trioxide—CCND1—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.0125	0.0218	CbGpPWpGaD
Arsenic trioxide—MAPK3—pancreas—sclerosing cholangitis	0.0123	0.0289	CbGeAlD
Arsenic trioxide—AKT1—pancreas—sclerosing cholangitis	0.0116	0.0273	CbGeAlD
Arsenic trioxide—CCND1—Coregulation of Androgen receptor activity—TCF4—sclerosing cholangitis	0.011	0.0191	CbGpPWpGaD
Arsenic trioxide—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0109	0.0189	CbGpPWpGaD
Arsenic trioxide—AKT1—Activation of BH3-only proteins—BCL2L11—sclerosing cholangitis	0.0107	0.0187	CbGpPWpGaD
Arsenic trioxide—AKT1—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0106	0.0185	CbGpPWpGaD
Arsenic trioxide—CCND1—liver—sclerosing cholangitis	0.0105	0.0247	CbGeAlD
Arsenic trioxide—CCND1—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.0102	0.0178	CbGpPWpGaD
Arsenic trioxide—JUN—pancreas—sclerosing cholangitis	0.0101	0.0238	CbGeAlD
Arsenic trioxide—AKT1—FoxO family signaling—MST1—sclerosing cholangitis	0.00993	0.0173	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00962	0.0167	CbGpPWpGaD
Arsenic trioxide—MAPK1—liver—sclerosing cholangitis	0.00886	0.0208	CbGeAlD
Arsenic trioxide—CCND1—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—sclerosing cholangitis	0.00885	0.0154	CbGpPWpGaD
Arsenic trioxide—IKBKB—FoxO family signaling—MST1—sclerosing cholangitis	0.00876	0.0153	CbGpPWpGaD
Arsenic trioxide—TXNRD1—liver—sclerosing cholangitis	0.00824	0.0194	CbGeAlD
Arsenic trioxide—MAPK3—liver—sclerosing cholangitis	0.00784	0.0184	CbGeAlD
Arsenic trioxide—AKT1—Intrinsic Pathway for Apoptosis—BCL2L11—sclerosing cholangitis	0.00767	0.0134	CbGpPWpGaD
Arsenic trioxide—AKT1—liver—sclerosing cholangitis	0.00739	0.0174	CbGeAlD
Arsenic trioxide—CCND1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00728	0.0127	CbGpPWpGaD
Arsenic trioxide—CCND1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00719	0.0125	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00699	0.0122	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis—TNFRSF25—sclerosing cholangitis	0.00671	0.0117	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNFRSF25—sclerosing cholangitis	0.00645	0.0112	CbGpPWpGaD
Arsenic trioxide—JUN—liver—sclerosing cholangitis	0.00643	0.0151	CbGeAlD
Arsenic trioxide—IKBKB—liver—sclerosing cholangitis	0.0064	0.015	CbGeAlD
Arsenic trioxide—JUN—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.0063	0.011	CbGpPWpGaD
Arsenic trioxide—AKT1—FoxO family signaling—BCL2L11—sclerosing cholangitis	0.00626	0.0109	CbGpPWpGaD
Arsenic trioxide—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00611	0.0106	CbGpPWpGaD
Arsenic trioxide—JUN—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00603	0.0105	CbGpPWpGaD
Arsenic trioxide—MAPK3—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00587	0.0102	CbGpPWpGaD
Arsenic trioxide—AKT1—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.00573	0.00999	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—TNFRSF25—sclerosing cholangitis	0.00569	0.00992	CbGpPWpGaD
Arsenic trioxide—IKBKB—FoxO family signaling—BCL2L11—sclerosing cholangitis	0.00553	0.00963	CbGpPWpGaD
Arsenic trioxide—MAPK1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00534	0.00931	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00534	0.0093	CbGpPWpGaD
Arsenic trioxide—MAPK1—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.00529	0.00922	CbGpPWpGaD
Arsenic trioxide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00511	0.0089	CbGpPWpGaD
Arsenic trioxide—AKT1—Coregulation of Androgen receptor activity—TCF4—sclerosing cholangitis	0.00505	0.00879	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00502	0.00874	CbGpPWpGaD
Arsenic trioxide—JUN—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.0049	0.00853	CbGpPWpGaD
Arsenic trioxide—CCND1—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00487	0.00848	CbGpPWpGaD
Arsenic trioxide—AKT1—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00476	0.00829	CbGpPWpGaD
Arsenic trioxide—AKT1—Angiogenesis—HIF1A—sclerosing cholangitis	0.00471	0.00821	CbGpPWpGaD
Arsenic trioxide—TXNRD1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00466	0.00812	CbGpPWpGaD
Arsenic trioxide—CCND1—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00455	0.00792	CbGpPWpGaD
Arsenic trioxide—JUN—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00453	0.00789	CbGpPWpGaD
Arsenic trioxide—AKT1—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00446	0.00777	CbGpPWpGaD
Arsenic trioxide—CCND1—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.00436	0.00759	CbGpPWpGaD
Arsenic trioxide—AKT1—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00435	0.00758	CbGpPWpGaD
Arsenic trioxide—MAPK1—Angiogenesis—HIF1A—sclerosing cholangitis	0.00435	0.00758	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis—BCL2L11—sclerosing cholangitis	0.00423	0.00737	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—sclerosing cholangitis	0.00423	0.00737	CbGpPWpGaD
Arsenic trioxide—MAPK3—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00422	0.00735	CbGpPWpGaD
Arsenic trioxide—IKBKB—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.0042	0.00732	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—BCL2L11—sclerosing cholangitis	0.00407	0.00708	CbGpPWpGaD
Arsenic trioxide—AKT1—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.00405	0.00706	CbGpPWpGaD
Arsenic trioxide—MAPK1—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00402	0.00699	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00397	0.00692	CbGpPWpGaD
Arsenic trioxide—MAPK3—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.00393	0.00684	CbGpPWpGaD
Arsenic trioxide—IKBKB—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00384	0.00669	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00383	0.00667	CbGpPWpGaD
Arsenic trioxide—MAPK1—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.00374	0.00651	CbGpPWpGaD
Arsenic trioxide—MAPK3—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.0037	0.00644	CbGpPWpGaD
Arsenic trioxide—IKBKB—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.00366	0.00638	CbGpPWpGaD
Arsenic trioxide—AKT1—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00363	0.00633	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—BCL2L11—sclerosing cholangitis	0.00359	0.00625	CbGpPWpGaD
Arsenic trioxide—MAPK3—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00352	0.00614	CbGpPWpGaD
Arsenic trioxide—ABCC2—liver—sclerosing cholangitis	0.0035	0.00823	CbGeAlD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00348	0.00606	CbGpPWpGaD
Arsenic trioxide—JUN—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00344	0.00599	CbGpPWpGaD
Arsenic trioxide—CYP1B1—liver—sclerosing cholangitis	0.00343	0.00806	CbGeAlD
Arsenic trioxide—IKBKB—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00337	0.00587	CbGpPWpGaD
Arsenic trioxide—MAPK1—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00335	0.00584	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00334	0.00582	CbGpPWpGaD
Arsenic trioxide—AKT1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.0033	0.00575	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.0033	0.00575	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00324	0.00565	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00315	0.00549	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00313	0.00545	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00309	0.00537	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling by NOTCH—HIF1A—sclerosing cholangitis	0.00306	0.00533	CbGpPWpGaD
Arsenic trioxide—MAPK1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00305	0.00531	CbGpPWpGaD
Arsenic trioxide—JUN—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00275	0.00479	CbGpPWpGaD
Arsenic trioxide—AKT1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00264	0.0046	CbGpPWpGaD
Arsenic trioxide—CCND1—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00261	0.00455	CbGpPWpGaD
Arsenic trioxide—MAPK3—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00256	0.00446	CbGpPWpGaD
Arsenic trioxide—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0025	0.00436	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—BCL2L11—sclerosing cholangitis	0.00249	0.00434	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00245	0.00426	CbGpPWpGaD
Arsenic trioxide—MAPK1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00244	0.00425	CbGpPWpGaD
Arsenic trioxide—JUN—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00243	0.00423	CbGpPWpGaD
Arsenic trioxide—CYP1A1—liver—sclerosing cholangitis	0.00243	0.00569	CbGeAlD
Arsenic trioxide—IKBKB—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00233	0.00406	CbGpPWpGaD
Arsenic trioxide—AKT1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00233	0.00406	CbGpPWpGaD
Arsenic trioxide—MAPK3—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00226	0.00394	CbGpPWpGaD
Arsenic trioxide—AKT1—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00223	0.00389	CbGpPWpGaD
Arsenic trioxide—JUN—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00218	0.0038	CbGpPWpGaD
Arsenic trioxide—JUN—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00218	0.0038	CbGpPWpGaD
Arsenic trioxide—JUN—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00217	0.00378	CbGpPWpGaD
Arsenic trioxide—MAPK1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00215	0.00375	CbGpPWpGaD
Arsenic trioxide—AKT1—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00212	0.0037	CbGpPWpGaD
Arsenic trioxide—AKT1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.0021	0.00365	CbGpPWpGaD
Arsenic trioxide—AKT1—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.0021	0.00365	CbGpPWpGaD
Arsenic trioxide—JUN—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.00208	0.00363	CbGpPWpGaD
Arsenic trioxide—MAPK3—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00206	0.00359	CbGpPWpGaD
Arsenic trioxide—IKBKB—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00206	0.00358	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00206	0.00358	CbGpPWpGaD
Arsenic trioxide—MAPK3—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00204	0.00354	CbGpPWpGaD
Arsenic trioxide—MAPK3—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00202	0.00353	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00202	0.00352	CbGpPWpGaD
Arsenic trioxide—JUN—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00199	0.00346	CbGpPWpGaD
Arsenic trioxide—JUN—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00199	0.00346	CbGpPWpGaD
Arsenic trioxide—ABCB1—pancreas—sclerosing cholangitis	0.00198	0.00465	CbGeAlD
Arsenic trioxide—MAPK1—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00196	0.00341	CbGpPWpGaD
Arsenic trioxide—MAPK1—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00194	0.00337	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00193	0.00336	CbGpPWpGaD
Arsenic trioxide—MAPK1—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00193	0.00336	CbGpPWpGaD
Arsenic trioxide—AKT1—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00191	0.00332	CbGpPWpGaD
Arsenic trioxide—AKT1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00191	0.00332	CbGpPWpGaD
Arsenic trioxide—AKT1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00189	0.00328	CbGpPWpGaD
Arsenic trioxide—IKBKB—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00185	0.00323	CbGpPWpGaD
Arsenic trioxide—MAPK3—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00185	0.00322	CbGpPWpGaD
Arsenic trioxide—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00183	0.00319	CbGpPWpGaD
Arsenic trioxide—CYP3A4—liver—sclerosing cholangitis	0.00178	0.00418	CbGeAlD
Arsenic trioxide—MAPK1—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00176	0.00307	CbGpPWpGaD
Arsenic trioxide—MAPK1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00174	0.00303	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—ABCB4—sclerosing cholangitis	0.00171	0.00297	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00169	0.00294	CbGpPWpGaD
Arsenic trioxide—IKBKB—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00169	0.00294	CbGpPWpGaD
Arsenic trioxide—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00167	0.0029	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00157	0.00273	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00153	0.00266	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00148	0.00258	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling by NOTCH—HIF1A—sclerosing cholangitis	0.00146	0.00255	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00141	0.00245	CbGpPWpGaD
Arsenic trioxide—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00139	0.00242	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00137	0.00238	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00136	0.00236	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00135	0.00235	CbGpPWpGaD
Arsenic trioxide—ABCB1—liver—sclerosing cholangitis	0.00126	0.00296	CbGeAlD
Arsenic trioxide—CYP1B1—Biological oxidations—GGT1—sclerosing cholangitis	0.00117	0.00203	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00116	0.00203	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00111	0.00193	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.0011	0.00191	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00109	0.0019	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TCF4—sclerosing cholangitis	0.000947	0.00165	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TCF4—sclerosing cholangitis	0.000918	0.0016	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TCF4—sclerosing cholangitis	0.000874	0.00152	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000858	0.00149	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000815	0.00142	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—GOT2—sclerosing cholangitis	0.00081	0.00141	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00078	0.00136	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00072	0.00125	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.000717	0.00125	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000714	0.00124	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—GGT1—sclerosing cholangitis	0.000699	0.00122	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—GOT1—sclerosing cholangitis	0.000699	0.00122	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000672	0.00117	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000671	0.00117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000639	0.00111	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000638	0.00111	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ABCB4—sclerosing cholangitis	0.000584	0.00102	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000486	0.000846	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000447	0.000779	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—NOS2—sclerosing cholangitis	0.000374	0.000652	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—NOS2—sclerosing cholangitis	0.000363	0.000632	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000353	0.000615	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—NOS2—sclerosing cholangitis	0.000345	0.000601	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000341	0.000594	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—GOT2—sclerosing cholangitis	0.000332	0.000577	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000328	0.000571	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—GOT2—sclerosing cholangitis	0.000322	0.00056	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000318	0.000554	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—GOT2—sclerosing cholangitis	0.000306	0.000533	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000304	0.000529	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000303	0.000527	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000299	0.000521	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000289	0.000504	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—GOT1—sclerosing cholangitis	0.000286	0.000498	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GOT2—sclerosing cholangitis	0.000278	0.000484	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—GOT1—sclerosing cholangitis	0.000278	0.000483	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000276	0.00048	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—GOT1—sclerosing cholangitis	0.000264	0.00046	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GGT1—sclerosing cholangitis	0.00024	0.000417	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GOT1—sclerosing cholangitis	0.00024	0.000417	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000239	0.000416	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GOT2—sclerosing cholangitis	0.000231	0.000402	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GGT1—sclerosing cholangitis	0.000199	0.000347	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GOT1—sclerosing cholangitis	0.000199	0.000347	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HIF1A—sclerosing cholangitis	0.000199	0.000347	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HIF1A—sclerosing cholangitis	0.000193	0.000336	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HIF1A—sclerosing cholangitis	0.000184	0.00032	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS2—sclerosing cholangitis	0.000181	0.000315	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS2—sclerosing cholangitis	0.000176	0.000306	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS2—sclerosing cholangitis	0.000167	0.000291	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000147	0.000256	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000145	0.000253	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	0.000142	0.000248	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000139	0.000243	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000135	0.000236	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000129	0.000224	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000123	0.000214	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	0.000123	0.000214	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	0.000123	0.000214	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000114	0.000198	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GGT1—sclerosing cholangitis	9.8e-05	0.000171	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GOT1—sclerosing cholangitis	9.8e-05	0.000171	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	6.99e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	6.04e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	6.04e-05	0.000105	CbGpPWpGaD
